Search Results 1551-1560 of 16895 for monoclonal antibody

1. Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma - Mayo Clinic

   ... antibody (HBcAb) test; patient must not have active hepatitis C virus (HCV) infection as evidenced by testing performed within 28 days prior to registration ...

2. Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - Mayo Clinic

   Patients positive for anti-HCV antibody will be eligible if they are negative for HCV-RNA. Cytomegalovirus (CMV) infection. Patients who are CMV PCR ...

3. Mayo-Adimune Collaborative and Programmatic Approach to Tolerization Therapy

   The purpose of this study is to target two autoimmune neurological conditions that we consider proof of principal T cell- and antibody ... antibody titer greater ...

4. Science Saturday: Thinking small for big possibilities - Mayo Clinic News Network

   Kim's team developed a new type of nanoparticle that actively engages the immune system to kill cancer cells. The nanoparticle is coated with antibodies that ...

5. ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders - Mayo Clinic

   Lupus anticoagulant ii. Anti-cardiolipin antibodies/Beta2 glycoprotein antibodies iii. Antiphospholipid syndrome. Exclusion Criteria 1. Acquired ...

6. A Study to Evaluate Chemoradiotherapy with or without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer - Mayo Clinic

   ... [antibody to hepatitis B core antigen] antibody test) are eligible;; Patients positive for hepatitis C virus (HCV) antibody are eligible only if polymerase ...

7. Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies - Mayo Clinic

   ... antibody therapy. Radiation therapy within 3 weeks prior to first dose. Radioimmunotherapy within 8 weeks prior to first dose. Localized radiation therapy ...

8. A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide - Mayo Clinic

   ... Antibody and Lenalidomide. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...

9. SC16LD6.5 in Recurrent Small Cell Lung Cancer - Mayo Clinic

   5 will be assessed by measuring the extent of tumor shrinkage. SC16LD6.5 is an antibody-drug conjugate (ADC). The antibody (SC16) targets a protein that appears ...

10. Transplant Medicine Clinical Trials - Medical Professionals

    ... antibodies against their donors are at a greater risk of rejection of their transplanted organs. Ultrasound Microvessel Imaging of Transplant Kidney.